Quality of life in advanced non-small cell lung cancer patients receiving palliative chemotherapy: A meta-analysis of randomized controlled trials

By      

Experimental and Therapeutic Medicine, Vol. 3, Iss. 1, 2012-01 ,pp. : 134-140

Spandidos Publications

Access to resources Recommend Favorite

Maintenance erlotinib improves clinical outcomes of unresectable advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

By Zhang Jian   Zhang Weiqing   Huang Shaohong   Li Hui   Li Yun   Chen Huiguo   Wu Weibing   Zhou Wei   Wang Cuiping   Liao Hongying   Gu Lijia  

Experimental and Therapeutic Medicine, Vol. 4, Iss. 5, 2012-11 ,pp. : 849-858

Spandidos Publications

Access to resources Recommend Favorite

Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials

By Cao Chao   Wang Jianmiao   Bunjhoo Hansvin   Xu Yongjian   Fang Huijuan  

Acta Oncologica, Vol. 51, Iss. 2, 2012-02 ,pp. : 151-156

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of capecitabine combined with docetaxel in previously treated patients with non-small cell lung cancer: A randomized controlled study

By                        

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 761-766

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer

By Oki Yasunari   Hirose Takashi   Yamaoka Toshimitsu   Kusumoto Sojiro   Shirai Takao   Sugiyama Tomohide   Okuda Kentaro   Nakashima Masanao   Murata Yasunori   Ohmori Tohru   Adachi Mitsuru  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 791-797

Springer Publishing Company

Access to resources Recommend Favorite